Ursodeoxycholic acid is associated with a reduction in SARS‐CoV‐2 infection and reduced severity of COVID‐19 in patients with cirrhosis

Overview of attention for article published in Journal of Internal Medicine, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#49 of 4,124)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 33 news outlets
blogs: 1 blog
twitter: 25 X users

facebook: 1 Facebook page
reddit: 1 Redditor

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 33 news stories from 33 outlets.

Ursodeoxycholic Acid Reduces SARS-CoV-2 Infection, Severity

Rheumatology Advisor, 12 Apr 2023

HealthDay News — Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (S…

Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity

MPR, 11 Apr 2023

Credit:. Ursodeoxycholic acid exposure among participants with cirrhosis tied to reduced odds of developing SARS-CoV-2…

Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity

Drugs.com, 10 Apr 2023

News Professional By Lori Solomon HealthDay Reporter MONDAY, April 10, 2023 -- Ursodeoxycholic acid (UDCA) is associated with a…

Ursodeoxycholic acid cuts SARS-CoV-2 infection, severity

McKnights Senior Living, 10 Apr 2023

(HealthDay News) — Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 29 additional news stories.